Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 521,865 | 322,368 | 432,871 | 414,619 | 483,235 |
| Marketable Securities | 38,052 | 81,356 | 83,925 | 95,233 | 108,742 |
| Receivables | 5,170 | 8,614 | 10,761 | 17,079 | 24,581 |
| TOTAL | $587,670 | $432,884 | $552,702 | $548,853 | $642,219 |
| Non-Current Assets | |||||
| PPE Net | 12,413 | 13,047 | 13,566 | 14,569 | 15,603 |
| Intangibles | 26,917 | 27,515 | 28,113 | 28,712 | 29,310 |
| Other Non-Current Assets | 28,008 | 30,215 | 31,299 | 30,902 | 41,608 |
| TOTAL | $67,338 | $70,777 | $72,978 | $74,183 | $86,521 |
| Total Assets | $655,008 | $503,661 | $625,680 | $623,036 | $728,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,472 | 3,874 | 4,076 | 11,558 | 10,158 |
| Accrued Expenses | 90,864 | 96,260 | 59,948 | 98,039 | 73,636 |
| TOTAL | $106,065 | $110,120 | $96,596 | $121,428 | $119,194 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,721,081 | 1,718,937 | 1,713,292 | 1,707,615 | 1,698,693 |
| Deferred Revenues | 6,592 | 6,210 | 6,675 | 8,156 | 7,518 |
| Other Non-Current Liabilities | 25,489 | 27,379 | 31,777 | 40,307 | 41,692 |
| TOTAL | $1,744,081 | $1,743,512 | $1,742,493 | $1,744,943 | $1,737,531 |
| Total Liabilities | $1,850,146 | $1,853,632 | $1,839,089 | $1,866,371 | $1,856,725 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 173,967 | 162,472 | 160,501 | 151,373 | 149,483 |
| Common Shares | 180 | 168 | 167 | 157 | 156 |
| Retained earnings | -2,392,353 | -2,215,354 | -2,057,455 | -1,918,149 | -1,780,558 |
| Other shareholders' equity | 12,439 | 12,115 | 12,244 | 10,954 | 10,084 |
| TOTAL | $-1,195,138 | $-1,349,971 | $-1,213,409 | $-1,243,335 | $-1,127,985 |
| Total Liabilities And Equity | $655,008 | $503,661 | $625,680 | $623,036 | $728,740 |